Coronary Artery-Specific Changes in Patients with Chronic Kidney Disease

Julia Hanke1, Katarzyna Romejko1, Stanisław Niemczyk1

  • 1Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine-National Research Institute, 128 Szaserów Street, 04-141 Warsaw, Poland.

Cells
|May 13, 2026
PubMed

Insights

Chronic kidney disease (CKD) accelerates coronary artery disease through inflammation and calcification, affecting both large vessels and small vessels. Early CKD-specific interventions are crucial for cardiovascular risk prevention.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Pathology

Background:

  • Cardiovascular disease (CVD) is the leading cause of death in chronic kidney disease (CKD) patients.
  • Coronary artery pathology in CKD differs significantly from traditional atherosclerosis.
  • CKD creates a unique environment promoting vascular damage.

Purpose of the Study:

  • To review coronary artery alterations specific to CKD.
  • To explore mechanisms driving atherogenesis, plaque characteristics, calcification, and microvascular dysfunction in CKD.
  • To highlight the distinct nature of CVD in CKD.

Main Methods:

  • Literature review focusing on coronary artery pathology in CKD.
  • Analysis of mechanisms promoting inflammation, oxidative stress, and calcification.
  • Examination of plaque composition, calcific remodeling, and microvascular function.

Main Results:

  • CKD promotes a pro-inflammatory, pro-oxidative, and pro-calcific milieu, leading to endothelial damage and vascular calcification.
  • Coronary plaques in CKD feature larger lipid cores, increased inflammation, significant calcification, and vulnerability.
  • Coronary microvascular dysfunction is common in CKD, contributing to ischemia.

Conclusions:

  • CKD is associated with a distinct, accelerated form of coronary artery disease driven by calcification and inflammation.
  • This CKD-specific CVD involves both macrovascular plaque changes and microvascular dysfunction.
  • Targeting CKD-specific mechanisms alongside conventional risk factors is essential for CVD prevention in these patients.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...